Register
Login:
Share:
Email Facebook Twitter

RNS VIDEO: Reabold Resources #RBD raise £6 million and take stake in Danube Petroleum Watch here

EXCLUSIVE: HemoGenyx are creating blood cancer treatments with US$9 billion market potential


ShareCast News - AIM Bulletin





Evgen raises 2.3m as Sulforadex trials progress

(ShareCast News) - Virtual pharmaceutical company Evgen announced on Monday that it was progressing in Phase II clinical trials of SFX-01 for both subarachnoid haemorrhage and ER+ breast cancer, with readouts expected at or around the end of 2018.
[11 Dec '17 13:17]

AorTech reaches settlement in Utah litigation

(ShareCast News) - Biomaterials and medical device intellectual property company AorTech International announced the end of its litigation with the Foldax defendants on Monday.
[11 Dec '17 13:13]

SatoshiPay set to accept credit card payments, says Blue Star Capital

(ShareCast News) - Technology-focussed investing company Blue Star Capital announced on Monday that, further to its update on 13 November regarding its investee company SatoshiPay, it could confirm that SatoshiPay's partnership with Stellar was now 'live'.
[11 Dec '17 13:07]

Real Estate Investors sells Birmingham property, announces Leicester letting

(ShareCast News) - Midlands focused property group Real Estate Investors has sold 24 Bennetts Hill, Birmingham, for a cash consideration of 4m and completed a major letting in Leicester.
[11 Dec '17 10:41]

Randall & Quilter enters Malta underwriting agreements

(ShareCast News) - AIM-listed Randall & Quilter's Malta subsidiary has entered into delegated underwriting agreements with UK motor insurance providers Xpekt and Blagrove Underwriting Agency.
[11 Dec '17 09:41]

Plus500 gets Singapore operating licence

(ShareCast News) - AIM-listed online trading platform provider Plus500 has been granted an operating licence in Singapore to deal in securities and leveraged foreign exchange trading
[11 Dec '17 09:26]

Enteq Upstream signs on new international customer

(ShareCast News) - Oilfield services technology and equipment supplier Enteq Upstream announced a contract from a new, unnamed international customer on Friday.
[8 Dec '17 16:01]

Vela agrees to invest 0.2m in cryptocurrency mining firm BlockchainK2

(ShareCast News) - Technology investing company Vela has entered into a conditional agreement to invest 0.2m to acquire a minority equity stake in BlockchainK2, it announced on Friday.
[8 Dec '17 15:36]

Touchstone Exploration planning 3m private placement

(ShareCast News) - Touchstone Exploration intends to complete a private placement directed towards UK-based institutional investors, it announced on Friday.
[8 Dec '17 15:34]

ANGLE confirms recent positive Parsortix tests

(ShareCast News) - Liquid biopsy company ANGLE announced on Friday that the University of Southern California's Norris Comprehensive Cancer Center has presented results of extensive work with its 'Parsortix' system at the San Antonio Breast Cancer Symposium, detailing how the system could be used to obtain comparable gene expression information from a simple blood test in place of an invasive solid tissue biopsy of a metastatic site.
[8 Dec '17 15:01]



Categories: AIM Bulletin, Broker Recommendations, Commodities, Company News, Dealings and Holdings, Economic News, Foreign Exchange, International News, Market Report, New Issues, News and Announcements, Press Round-Up, Risers and Fallers, Small Cap News, Technical Analysis, Tips Round-Up, Week Ahead.


Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk




Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.